SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors.
SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors.
复制标题
DOI:
10.1016/j.lungcan.2012.02.017
复制
发表时间:
2012-07
期刊:
影响因子:
--
通讯作者:
Yang P
中科院分区:
文献类型:
--
作者:
Rausch SM;Gonzalez BD;Clark MM;Patten C;Felten S;Liu H;Li Y;Sloan J;Yang P
Lung cancer survivors report the lowest quality of life relative to other cancer survivors. Pain is one of the most devastating, persistent, and incapacitating symptoms for lung cancer survivors. Prevalence rates vary with 80–100% of survivors experiencing cancer pain and healthcare costs are five times higher in cancer survivors with uncontrolled pain. Cancer pain often has a considerable impact on quality of life among cancer patients and cancer survivors. Therefore, early identification, and treatment is important. Although recent studies have suggested a relationship between single nucleotide polymorphisms (SNPs) in several cytokine and inflammation genes with cancer prognosis, associations with cancer pain are not clear. Therefore, the primary aim of this study was to identify SNPs related to pain in long term lung cancer survivors. Participants were enrolled in the Mayo Clinic Lung Cancer Cohort upon diagnosis of their lung cancer. 1149 Caucasian lung cancer survivors, (440 surviving < 3 years; 354 surviving 3–5 years; and 355 surviving> 5 years) completed study questionnaires and had genetic samples available. Ten SNPS from PTGS2 and LTA genes were selected based on the serum literature. Outcomes included pain, and quality of life as measured by the SF-8. Of the 10 SNPs evaluated in LTA and PTGS2 genes, 3 were associated with pain severity (rs5277; rs1799964), social function (rs5277) and mental health (rs5275). These results suggested both specificity and consistency of these inflammatory gene SNPs in predicting pain severity in long term lung cancer survivors. These results provide support for genetic predisposition to pain severity and may aid in identification of lung cancer survivors at high risk for morbidity and poor QOL.
登录
查看更多内容
DOI:
10.1016/j.ijrobp.2004.12.027
发表时间:
2005-07-15
影响因子:
7
作者:
De Ruyck, K;Van Eijkeren, M;Thierens, H
通讯作者:
Thierens, H
影响因子:
6
作者:
Hjelmström, P;Fjell, J;Ruddle, NH
通讯作者:
Ruddle, NH
影响因子:
5.3
作者:
Constantin, Cristina E.;Mair, Norbert;Kress, Michaela
通讯作者:
Kress, Michaela
DOI:
10.1016/j.ijrobp.2005.09.014
发表时间:
2006-03-01
影响因子:
7
作者:
Andreassen, CN;Overgaard, J;Rosenstein, BS
通讯作者:
Rosenstein, BS
影响因子:
7.4
作者:
de Wit, R;van Dam, F;Abu-Saad, HH
通讯作者:
Abu-Saad, HH